200 related articles for article (PubMed ID: 28766223)
1. Differences Among a Modern Cohort of BRCA Mutation Carriers Choosing Bilateral Prophylactic Mastectomies Compared to Breast Surveillance.
Gilbert E; Zabor EC; Stempel M; Mangino D; Heerdt A; Pilewskie M
Ann Surg Oncol; 2017 Oct; 24(10):3048-3054. PubMed ID: 28766223
[TBL] [Abstract][Full Text] [Related]
2. Preoperative risk assessment among women undergoing bilateral prophylactic mastectomy for cancer risk reduction.
Rueth NM; McMahon M; Arrington AK; Swenson K; Leach J; Tuttle TM
Ann Surg Oncol; 2011 Sep; 18(9):2515-20. PubMed ID: 21424371
[TBL] [Abstract][Full Text] [Related]
3. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
4. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.
Adem C; Reynolds C; Soderberg CL; Slezak JM; McDonnell SK; Sebo TJ; Schaid DJ; Myers JL; Sellers TA; Hartmann LC; Jenkins RB
Cancer; 2003 Jan; 97(1):1-11. PubMed ID: 12491499
[TBL] [Abstract][Full Text] [Related]
5. Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers.
Friebel TM; Domchek SM; Neuhausen SL; Wagner T; Evans DG; Isaacs C; Garber JE; Daly MB; Eeles R; Matloff E; Tomlinson G; Lynch HT; Tung N; Blum JL; Weitzel J; Rubinstein WS; Ganz PA; Couch F; Rebbeck TR
Clin Breast Cancer; 2007 Dec; 7(11):875-82. PubMed ID: 18269778
[TBL] [Abstract][Full Text] [Related]
6. Clinical Decision-Making in Patients with Variant of Uncertain Significance in BRCA1 or BRCA2 Genes.
Welsh JL; Hoskin TL; Day CN; Thomas AS; Cogswell JA; Couch FJ; Boughey JC
Ann Surg Oncol; 2017 Oct; 24(10):3067-3072. PubMed ID: 28766224
[TBL] [Abstract][Full Text] [Related]
7. Breast Cancer Risk Reduction Decisions of the BRCA-Positive Patient: An Observational Study at a Single Institution.
Johns D; Agarwal J; Anderson L; Ying J; Kohlmann W
J Womens Health (Larchmt); 2017 Jun; 26(6):702-706. PubMed ID: 27922795
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic and therapeutic mastectomy in BRCA mutation carriers: can the nipple be preserved?
Reynolds C; Davidson JA; Lindor NM; Glazebrook KN; Jakub JW; Degnim AC; Sandhu NP; Walsh MF; Hartmann LC; Boughey JC
Ann Surg Oncol; 2011 Oct; 18(11):3102-9. PubMed ID: 21947588
[TBL] [Abstract][Full Text] [Related]
9. Uptake of risk-reducing surgery in BRCA gene carriers in Wales, UK.
Long J; Evans TG; Bailey D; Lewis MH; Gower-Thomas K; Murray A
Breast J; 2018 Jul; 24(4):580-585. PubMed ID: 29286205
[TBL] [Abstract][Full Text] [Related]
10. Satisfaction and Impact on Quality of Life of Clinical and Instrumental Surveillance and Prophylactic Surgery in BRCA-mutation Carriers.
D'Alonzo M; Piva E; Pecchio S; Liberale V; Modaffari P; Ponzone R; Biglia N
Clin Breast Cancer; 2018 Dec; 18(6):e1361-e1366. PubMed ID: 30122348
[TBL] [Abstract][Full Text] [Related]
11. Patient-Reported Outcome Measures may optimize shared decision-making for cancer risk management in BRCA mutation carriers.
van Egdom LSE; de Kock MA; Apon I; Mureau MAM; Verhoef C; Hazelzet JA; Koppert LB
Breast Cancer; 2020 May; 27(3):426-434. PubMed ID: 31832891
[TBL] [Abstract][Full Text] [Related]
12. Trends in use of bilateral prophylactic mastectomy vs high-risk surveillance in unaffected carriers of inherited breast cancer syndromes in the Inherited Cancer Registry (ICARE).
Henry DA; Lee MC; Almanza D; Ahmed KA; Sun W; Boulware DC; Laronga C
Breast Cancer Res Treat; 2019 Feb; 174(1):39-45. PubMed ID: 30474778
[TBL] [Abstract][Full Text] [Related]
13. Cost Effectiveness of Risk-Reducing Mastectomy versus Surveillance in BRCA Mutation Carriers with a History of Ovarian Cancer.
Gamble C; Havrilesky LJ; Myers ER; Chino JP; Hollenbeck S; Plichta JK; Kelly Marcom P; Shelley Hwang E; Kauff ND; Greenup RA
Ann Surg Oncol; 2017 Oct; 24(11):3116-3123. PubMed ID: 28699130
[TBL] [Abstract][Full Text] [Related]
14. Occult Histopathology and Its Predictors in Contralateral and Bilateral Prophylactic Mastectomies.
Mattos D; Gfrerer L; Ling IT; Reish RG; Hughes KS; Halpern EF; Cetrulo C; Colwell AS; Winograd JM; Yaremchuk MJ; Austen WG; Liao EC
Ann Surg Oncol; 2016 Mar; 23(3):767-75. PubMed ID: 26577123
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
16. Preoperative Panel Testing for Hereditary Cancer Syndromes Does Not Significantly Impact Time to Surgery for Newly Diagnosed Breast Cancer Patients Compared with BRCA1/2 Testing.
Murphy AE; Hussain L; Ho C; Dunki-Jacobs E; Lee D; Tameron A; Huelsman K; Rice C; Wexelman BA
Ann Surg Oncol; 2017 Oct; 24(10):3055-3059. PubMed ID: 28766202
[TBL] [Abstract][Full Text] [Related]
17. Comparison of nodal metastasis between BRCA mutation carriers and non-BRCA mutation carriers with breast cancer.
Noori SF; Gangi A; Nelson ME; Choi M; Mirzadehgan P; Bonk AK; Mirocha J; Amersi F; Giuliano AE
Ann Surg Oncol; 2014 Oct; 21(10):3324-9. PubMed ID: 25047471
[TBL] [Abstract][Full Text] [Related]
18. One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery).
Lodder LN; Frets PG; Trijsburg RW; Meijers-Heijboer EJ; Klijn JG; Seynaeve C; van Geel AN; Tilanus MM; Bartels CC; Verhoog LC; Brekelmans CT; Burger CW; Niermeijer MF
Breast Cancer Res Treat; 2002 May; 73(2):97-112. PubMed ID: 12088120
[TBL] [Abstract][Full Text] [Related]
19. Total skin-sparing mastectomy in BRCA mutation carriers.
Peled AW; Irwin CS; Hwang ES; Ewing CA; Alvarado M; Esserman LJ
Ann Surg Oncol; 2014 Jan; 21(1):37-41. PubMed ID: 23982256
[TBL] [Abstract][Full Text] [Related]
20. Differences among a Portuguese cohort of BRCA pathogenic/likely pathogenic variants carriers choosing risk-reducing mastectomy or intensive breast surveillance.
Torres S; Peleteiro B; Magalhães A; Garrido L; Costa S; Fougo JL
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7529-7538. PubMed ID: 36971799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
